• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ENDOLOGIX AFX2; BIFURCATED STENT GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ENDOLOGIX AFX2; BIFURCATED STENT GRAFT Back to Search Results
Model Number BEA25-100/I16-40
Device Problems Material Puncture/Hole (1504); Stretched (1601); Material Integrity Problem (2978)
Patient Problems Failure of Implant (1924); No Code Available (3191)
Event Type  Injury  
Manufacturer Narrative
The device involved in the event will not be returned for evaluation as it remains implanted in the patient.If additional information pertinent to the incident is obtained, a follow-up report will be submitted.
 
Event Description
The patient was initially implanted with a bifurcated stent graft and a suprarenal stent graft extension to treat an abdominal aortic aneurysm (aaa).Approximately one (1) year post initial procedure, a type 3b endoleak was discovered during a routine follow up.The exact date of event is unknown.A secondary procedure was completed.The physician elected to reline the original implanted devices with non- endologix stent to treat the reported event.No further information was provided.
 
Manufacturer Narrative
The manufacturing lot evaluation confirmed all devices met specifications prior to release.The device was not returned as the device remains implanted therefore no evaluation was completed.At the completion of the clinical assessment, clinical was able to find substantial evidence to support the following events: the reported type 3b endoleak was refuted rather there was distal fabric billowing of the bifurcated stent graft and a type 2 endoleak from the internal mesenteric artery.The distal fabric billowing is not a device failure.The material is designed to stretch.The type 2 endoleak is anatomy related, a non-device related failure.No additional investigation of this reported event is planned however if additional information pertinent to the incident is obtained, a follow-up report will be submitted.Endologix will continue to monitor this complaint and similar complaints in the event further investigation is needed.Device iteration is afx2.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AFX2
Type of Device
BIFURCATED STENT GRAFT
Manufacturer (Section D)
ENDOLOGIX
2 musick
irvine CA 92618
MDR Report Key8558663
MDR Text Key143372296
Report Number2031527-2019-00214
Device Sequence Number1
Product Code MIH
UDI-Device Identifier00818009014726
UDI-Public(01)00818009014726(17)180612
Combination Product (y/n)N
PMA/PMN Number
P040002
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Remedial Action Recall
Type of Report Initial,Followup
Report Date 04/01/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/26/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/12/2018
Device Model NumberBEA25-100/I16-40
Device Lot Number1702323-014
Was Device Available for Evaluation? Yes
Date Manufacturer Received04/01/2019
Is This a Reprocessed and Reused Single-Use Device? Yes
Removal/Correction NumberDEVICE REMAINS IMPLANTED
Patient Sequence Number1
Treatment
VELA SUPRARENAL, LOT 1725055-010
Patient Outcome(s) Required Intervention;
Patient Age71 YR
-
-